| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6096536 | Gastroenterology | 2010 | 9 Pages |
Abstract
In patients with reflux symptoms despite PPI treatment, lesogaberan decreased the number of TLESRs and reflux episodes, and increased LES pressure compared with placebo. These findings support further evaluation of lesogaberan as an add-on treatment in patients partially responding to PPIs.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Guy E. Boeckxstaens, Hanneke Beaumont, Veerle Mertens, Hans Denison, Magnus Ruth, John Adler, Debra G. Silberg, Daniel Sifrim,